The members of the American Association for Cancer Research have elected Antoni Ribas as president-elect for 2019–2020. He will officially become president-elect at the AACR Annual Meeting 2019, to be held in Atlanta, March 29–April 3, and he will assume the presidency in April 2020 at the AACR Annual Meeting in San Diego.
As NCI and NIH funding is being deliberated in Congress, this year’s 2025 AACR Cancer Progress Report had an unequivocal message: With 20 new anticancer therapeutics, new uses for eight previously approved anticancer therapeutics, two new early detection tools, and several AI-powered diagnostics approved over the span of just one year, cancer research funding yields a good return on investment.
